Teladoc Health Reports 3% Q3 Revenue Decline, Narrows Loss And Raises Adjusted EBITDA
Teladoc Health (TDOC) reported Q3 2026 revenue of $605.1M, down 3% YoY, but narrowed net loss to $26.9M and raised adjusted EBITDA by 14% to $79.4M. Integrated Care revenue grew 2%, while BetterHelp declined 13%. The company maintained its full-year 2026 outlook, expecting revenue of $2.395B-$2.441B and adjusted EBITDA of $277M-$303M.
How this was made
The 30-second read
Why it matters
The earnings beat on loss and EBITDA guidance may prompt short‑term buying, but revenue contraction in BetterHelp remains a risk.
Market read
First‑report earnings for a mid‑cap telehealth firm; potential catalyst for sector and short‑term price movement.
What to watch
Potential competitive pressure from emerging digital health platforms and macro‑economic slowdown affecting discretionary health spending.
Background
Teladoc Health is a leading virtual‑care provider. The Q3 2026 results are the first public disclosure of its latest quarterly performance and guidance.
Ticker impact
Teladoc Health reported Q3 2026 earnings with a 3% revenue decline, narrowed net loss and raised adjusted EBITDA guidance.
likely modest upward pressure as investors price in better-than-expected profitability and guidance near the top of the range
The company posted a narrower loss and higher adjusted EBITDA than the prior year, and its guidance was near the upper end of its own range, which typically drives buying interest.
Market effects
Telehealth sector may see modest rally as Teladoc demonstrates profitability progress.
U.S. healthcare stocks could benefit from the positive earnings surprise.
Limited; impact confined to U.S. listed telehealth companies.
Counterpoint
The revenue decline and weakness in BetterHelp could signal longer‑term headwinds, suggesting caution.
Key entities
- companyTeladoc Health, Inc.
Provider of telehealth services, ticker TDOC.
